The House Energy & Commerce Committee on Wednesday (May 24) unanimously passed a wide-ranging bill that would expand site-neutral payments in Medicare drug administration and potentially sets the stage for further policies, despite New York Democrats’ and hospitals’ concerns and as Third Way called for policymakers to remove the exceptions to Medicare’s current site-neutral pay policies. The PATIENT Act (H.R. 3561) includes a policy, passed by the subcommittee last week, to phase in Medicare site-neutral pay for drug administration services...